Proteome analysis of the HIV-1 Gag interactome

Virology

Volumn 460-461, Issue 1, 2014, Pages 194-206

  Engeland, Christine E ^a   Brown, Nigel P ^b   Börner, Kathleen ^a,b   Schümann, Michael ^c   Krause, Eberhard ^c   Kaderali, Lars ^d   Müller, Gerd A ^e   Kräusslich, Hans Georg ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

HIV Gag; Virus host interactions

Indexed keywords

BIOLOGICAL FACTOR; CYTOSKELETON PROTEIN; GAG PROTEIN; HELICASE; LIGASE; MOLECULAR MOTOR; RNA; SMALL INTERFERING RNA; TRANSFER RNA LIGASE; TRANSLATION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEOMICS; RNA DEGRADATION; RNA INTERFERENCE; RNA TRANSPORT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

HIV GAG; VIRUS-HOST INTERACTIONS;

GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEOME; VIRUS REPLICATION;

EID: 84902082036     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.04.038     Document Type: Article

References (133)

1. Abrahamyan L.G., Chatel-Chaix L., Ajamian L., Milev M.P., Monette A., Clement J.F., Song R., Lehmann M., DesGroseillers L., Laughrea M., Boccaccio G., Mouland A.J. Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA. J. Cell Sci. 2010, 123(Pt 3):369-383.
2. Abudu A., Wang X., Dang Y., Zhou T., Xiang S.H., Zheng Y.H. Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity. J. Biol. Chem. 2012, 287(2):1220-1228.
3. Angenstein F., Evans A.M., Settlage R.E., Moran S.T., Ling S.C., Klintsova A.Y., Shabanowitz J., Hunt D.F., Greenough W.T. A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons. J. Neurosci. 2002, 22(20):8827-8837.
4. Ashburner M., Ball C.A., Blake J.A., Botstein D., Butler H., Cherry J.M., Davis A.P., Dolinski K., Dwight S.S., Eppig J.T., Harris M.A., Hill D.P., Issel-Tarver L., Kasarskis A., Lewis S., Matese J.C., Richardson J.E., Ringwald M., Rubin G.M., Sherlock G. Gene ontology. tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25:25-29.
5. Bader G.D., Hogue C.W. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf. 2003, 4:2.
6. Bennett E.M., Lever A.M., Allen J.F. Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, and inhibits phosphorylation of splicing factor SF2. J. Virol. 2004, 78(20):11303-11312.
7. Börner K., Hermle J., Sommer C., Brown N.P., Knapp B., Glass B., Kunkel J., Torralba G., Reymann J., Beil N., Beneke J., Pepperkok R., Schneider R., Ludwig T., Hausmann M., Hamprecht F., Erfle H., Kaderali L., Kräusslich H.G., Lehmann M.J. From experimental setup to bioinformatics. an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnol. J. 2010, 5:39-49.
8. Bouttier M., Saumet A., Peter M., Courgnaud V., Schmidt U., Cazevieille C., Bertrand E., Lecellier C.H. Retroviral GAG proteins recruit AGO2 on viral RNAs without affecting RNA accumulation and translation. Nucleic Acids Res. 2012, 40(2):775-786.
9. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926.
10. Brendel C., Rehbein M., Kreienkamp H.J., Buck F., Richter D., Kindler S. Characterization of Staufen 1 ribonucleoprotein complexes. Biochem. J. 2004, 384(Pt 2):239-246.
11. Burdick R., Smith J.L., Chaipan C., Friew Y., Chen J., Venkatachari N.J., Delviks-Frankenberry K.A., Hu W.S., Pathak V.K. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J. Virol. 2010, 84:10241-10253.
12. Bushman F.D., Malani N., Fernandes J., D'Orso I., Cagney G., Diamond T.L., Zhou H., Hazuda D.J., Espeseth A.S., König R., Bandyopadhyay S., Ideker T., Goff S.P., Krogan N.J., Frankel A.D., Young J.A., Chanda S.K. Host cell factors in HIV replication. meta-analysis of genome-wide studies. PLoS Pathog. 2009, 5:e1000437.
13. Camus G., Segura-Morales C., Molle D., Lopez-Verges S., Begon-Pescia C., Cazevieille C., Schu P., Bertrand E., Berlioz-Torrent C., Basyuk E. The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol. Biol. Cell 2007, 18(8):3193-3203.
14. Carlton J.G., Agromayor M., Martin-Serrano J. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(30):10541-10546.
15. Catrein I., Herrmann R., Bosserhoff A., Ruppert T. Experimental proof for a signal peptidase I like activity in Mycoplasma pneumoniae, but absence of a gene encoding a conserved bacterial type I SPase. FEBS J. 2005, 272:2892-2900.
16. Cen S., Guo F., Niu M., Saadatmand J., Deflassieux J., Kleiman L. The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 2004, 279:33177-33184.
17. Chable-Bessia C., Meziane O., Latreille D., Triboulet R., Zamborlini A., Wagschal A., Jacquet J.M., Reynes J., Levy Y., Saib A., Bennasser Y., Benkirane M. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009, 6:26.
18. Châtel-Chaix L., Clement J.F., Martel C., Beriault V., Gatignol A., DesGroseillers L., Mouland A.J. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol. Cell. Biol. 2004, 24:2637-2648.
19. Châtel-Chaix L., Boulay K., Mouland A.J., Desgroseillers L. The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminus. Retrovirology 2008, 5:41.
20. Chendrimada T.P., Gregory R.I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005, 436(7051):740-744.
21. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., Sowder R.C., Barsov E., Hood B.L., Fisher R.J., Nagashima K., Conrads T.P., Veenstra T.D., Lifson J.D., Ott D.E. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80:9039-9052.
22. Christensen H.S., Daher A., Soye K.J., Frankel L.B., Alexander M.R., Laine S., Bannwarth S., Ong C.L., Chung S.W., Campbell S.M., Purcell D.F., Gatignol A. Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J. Virol. 2007, 81(10):5121-5131.
23. Chukkapalli V., Ono A. Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J. Mol. Biol. 2011, 410(4):512-524.
24. Cimarelli A., Luban J. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 1999, 73:5388-5401.
25. Cimarelli A., Sandin S., Höglund S., Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 2000, 74:3046-3057.
26. Cochrane A.W., McNally M.T., Mouland A.J. The retrovirus RNA trafficking granule. from birth to maturity. Retrovirology 2006, 3:18.
27. Colgan J., Yuan H.E., Franke E.K., Luban J. Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 1996, 70:4299-4310.
28. Cooper J., Liu L., Woodruff E.A., Taylor H.E., Goodwin J.S., D'Aquila R.T., Spearman P., Hildreth J.E., Dong X. Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J. Biol. Chem. 2011, 286:28498-28510.
29. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008, 26:1367-1372.
30. Cristea I.M., Williams R., Chait B.T., Rout M.P. Fluorescent proteins as proteomic probes. Mol. Cell Proteomics 2005, 4:1933-1941.
31. Dinkins C., Arko-Mensah J., Deretic V. Autophagy and HIV. Semin. Cell Dev. Biol. 2010, 21(7):712-718.
32. Dong X., Li H., Derdowski A., Ding L., Burnett A., Chen X., Peters T.R., Dermody T.S., Woodruff E., Wang J.J., Spearman P. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 2005, 120:663-674.
33. Engeland C.E., Oberwinkler H., Schümann M., Krause E., Müller G.A., Kräusslich H.G. The cellular protein lyric interacts with HIV-1 Gag. J. Virol. 2011, 85(24):13322-13332.
34. Eyre T.A., Ducluzeau F., Sneddon T.P., Povey S., Bruford E.A., Lush M.J. The HUGO Gene Nomenclature Database, 2006 updates. Nucleic Acids Res. 2006, 34:D319-321.
35. Fackler O.T., Kräusslich H.G. Interactions of human retroviruses with the host cell cytoskeleton. Curr. Opin. Microbiol. 2006, 9:409-415.
36. Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., Lin J., Minguez P., Bork P., von Mering C., Jensen L.J. STRING v9.1. protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, 41(database issue):D808-D815.
37. Franke E.K., Yuan H.E., Luban J. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 1994, 372:359-362.
38. Fu W., Sanders-Beer B.E., Katz K.S., Maglott D.R., Pruitt K.D., Ptak R.G. Human immunodeficiency virus type 1, human protein interaction database at NCBI. Nucleic Acids Res. 2009, 37:D417-D422.
39. Fukuhara T., Hosoya T., Shimizu S., Sumi K., Oshiro T., Yoshinaka Y., Suzuki M., Yamamoto N., Herzenberg L.A., Herzenberg L.A., Hagiwara M. Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(30):11329-11333.
40. Furtak V., Mulky A., Rawlings S.A., Kozhaya L., Lee K., Kewalramani V.N., Unutmaz D. Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS ONE 2010, 5(2):e9081.
41. Gautier V.W., Gu L., O'Donoghue N., Pennington S., Sheehy N., Hall W.W. in vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology 2009, 6:47.
42. Gingras A.C., Aebersold R., Raught B. Advances in protein complex analysis using mass spectrometry. J. Physiol. (Lond.) 2005, 563:11-21.
43. Gladnikoff M., Shimoni E., Gov N.S., Rousso I. Retroviral assembly and budding occur through an actin-driven mechanism. Biophys. J. 2009, 97(9):2419-2428.
44. Goila-Gaur R., Strebel K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 2008, 5:51.
45. Gurer C., Cimarelli A., Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. J. Virol. 2002, 76:4666-4670.
46. Hermida-Matsumoto L., Resh M.D. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J. Virol. 2000, 74:8670-8679.
47. Hong S., Choi G., Park S., Chung A.S., Hunter E., Rhee S.S. Type D retrovirus Gag polyprotein interacts with the cytosolic chaperonin TRiC. J. Virol. 2001, 75(6):2526-2534.
48. Huang d.a.W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4(1):44-57.
49. Huang d.a.W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools. paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37(1):1-13.
50. Hultquist J.F., Lengyel J.A., Refsland E.W., LaRue R.S., Lackey L., Brown W.L., Harris R.S. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. J. Virol. 2011, 85(21):11220-11234.
51. Hunter S., Jones P., Mitchell A., Apweiler R., Attwood T.K., Bateman A., Bernard T., Binns D., Bork P., Burge S., de Castro E., Coggill P., Corbett M., Das U., Daugherty L., Duquenne L., Finn R.D., Fraser M., Gough J., Haft D., Hulo N., Kahn D., Kelly E., Letunic I., Lonsdale D., Lopez R., Madera M., Maslen J., McAnulla C., McDowall J., McMenamin C., Mi H., Mutowo-Muellenet P., Mulder N., Natale D., Orengo C., Pesseat S., Punta M., Quinn A.F., Rivoire C., Sangrador-Vegas A., Selengut J.D., Sigrist C.J., Scheremetjew M., Tate J., Thimmajanarthanan M., Thomas P.D., Wu C.H., Yeats C., Yong S.Y. InterPro in 2011. new developments in the family and domain prediction database. Nucleic Acids Res. 2012, 40(database issue):D306-D312.
52. Jablonski J.A., Caputi M. Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J. Virol. 2009, 83(2):981-992.
53. Jacquenet S., Decimo D., Muriaux D., Darlix J.L. Dual effect of the SR proteins ASF/SF2 SC35, and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2005, 2:33.
54. Jäger S., Cimermancic P., Gulbahce N., Johnson J.R., McGovern K.E., Clarke S.C., Shales M., Mercenne G., Pache L., Li K., Hernandez H., Jang G.M., Roth S.L., Akiva E., Marlett J., Stephens M., D'Orso I., Fernandes J., Fahey M., Mahon C., O'Donoghue A.J., Todorovic A., Morris J.H., Maltby D.A., Alber T., Cagney G., Bushman F.D., Young J.A., Chanda S.K., Sundquist W.I., Kortemme T., Hernandez R.D., Craik C.S., Burlingame A., Sali A., Frankel A.D., Krogan N.J. Global landscape of HIV-human protein complexes. Nature 2012, 481(7381):365-370.
55. Javanbakht H., Halwani R., Cen S., Saadatmand J., Musier-Forsyth K., Gottlinger H., Kleiman L. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J. Biol. Chem. 2003, 278:27644-27651.
56. Jolly C., Mitar I., Sattentau Q.J. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J. Virol. 2007, 81(11):5547-5560.
57. Jonson L., Vikesaa J., Krogh A., Nielsen L.K., Hansen T.v., Borup R., Johnsen A.H., Christiansen J., Nielsen F.C. Molecular composition of IMP1 ribonucleoprotein granules. Mol. Cell Proteomics 2007, 6(5):798-811.
58. Joshi P., Stoddart C.A. Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1. J. Biol. Chem. 2011, 286(28):24581-24592.
59. Joshi P., Sloan B., Torbett B.E., Stoddart C.A. Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores. Virology 2013, 436(1):162-172.
60. Kanehisa M., Goto S. KEGG. kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28:27-30.
61. Klase Z., Houzet L., Jeang K.T. MicroRNAs and HIV-1. complex interactions. J. Biol. Chem. 2012, 287(49):40884-40890.
62. Kleiman L., Jones C.P., Musier-Forsyth K. Formation of the tRNALys packaging complex in HIV-1. FEBS Lett. 2010, 584(2):359-365.
63. König R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., Seidel S., Opaluch A.M., Caldwell J.S., Weitzman M.D., Kuhen K.L., Bandyopadhyay S., Ideker T., Orth A.P., Miraglia L.J., Bushman F.D., Young J.A., Chanda S.K. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60.
64. Kozak S.L., Marin M., Rose K.M., Bystrom C., Kabat D. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 2006, 281(39):29105-29119.
65. Kyei G.B., Dinkins C., Davis A.S., Roberts E., Singh S.B., Dong C., Wu L., Kominami E., Ueno T., Yamamoto A., Federico M., Panganiban A., Vergne I., Deretic V. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 2009, 186(2):255-268.
66. Lange S., Sylvester M., Schümann M., Freund C., Krause E. Identification of phosphorylation-dependent interaction partners of the adapter protein ADAP using quantitative mass spectrometry. SILAC vs (18)O-labeling. J. Proteome Res. 2010, 9:4113-4122.
67. Lehmann M., Milev M.P., Abrahamyan L., Yao X.J., Pante N., Mouland A.J. Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem. 2009, 284(21):14572-14585.
68. Li X., Li Y., Stremlau M., Yuan W., Song B., Perron M., Sodroski J. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains. J. Virol. 2006, 80:6198-6206.
69. Lingappa J.R., Dooher J.E., Newman M.A., Kiser P.K., Klein K.C. Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly. J. Biol. Chem. 2006, 281:3773-3784.
70. Liu B., Dai R., Tian C.J., Dawson L., Gorelick R., Yu X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 1999, 73:2901-2908.
71. Luban J., Bossolt K.L., Franke E.K., Kalpana G.V., Goff S.P. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 1993, 73:1067-1078.
72. Lund N., Milev M.P., Wong R., Sanmuganantham T., Woolaway K., Chabot B., Abou Elela S., Mouland A.J., Cochrane A. Differential effects of hnRNP D/AUF1 isoforms on HIV-1 gene expression. Nucleic Acids Res. 2012, 40(8):3663-3675.
73. Ma J., Rong L., Zhou Y., Roy B.B., Lu J., Abrahamyan L., Mouland A.J., Pan Q., Liang C. The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology 2008, 375(1):253-264.
74. Martinez N.W., Xue X., Berro R.G., Kreitzer G., Resh M.D. Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 2008, 82(20):9937-9950.
75. Martin-Serrano J. The role of ubiquitin in retroviral egress. Traffic 2007, 8(10):1297-1303.
76. Matrix Science Ltd., 2008. Mascot Version 2.2.04. URL: 〈〉. http://www.matrixscience.com.
77. Max Planck Institute of Biochemistry. Martinsried. Maxquant Contaminants. URL: 〈〉. http://www.biochem.mpg.de/en/rd/maxquant/Downloads/contaminants/contaminants.zip.
78. McCullough J., Colf L.A., Sundquist W.I. Membrane fission reactions of the mammalian ESCRT pathway. Annu. Rev. Biochem. 2013, 82:663-692.
79. Milev M.P., Brown C.M., Mouland A.J. Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1. Retrovirology 2010, 7:41.
80. Milev M.P., Ravichandran M., Khan M.F., Schriemer D.C., Mouland A.J. Characterization of staufen1 ribonucleoproteins by mass spectrometry and biochemical analyses reveal the presence of diverse host proteins associated with human immunodeficiency virus type 1. Front. Microbiol. 2012, 3:367.
81. Moser J.J., Fritzler M.J. Cytoplasmic ribonucleoprotein bodies and their relationship to GW/P bodies. Int. J. Biochem. Cell Biol. 2010, 42(6):828-843.
82. Mouland A.J., Mercier J., Luo M., Bernier L., DesGroseillers L., Cohen E.A. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1. evidence for a role in genomic RNA encapsidation. J. Virol. 2000, 74:5441-5451.
83. Müller B., Daecke J., Fackler O.T., Dittmar M.T., Zentgraf H., Kräusslich H.G. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 2004, 78:10803-10813.
84. Naghavi M.H., Goff S.P. Retroviral proteins that interact with the host cell cytoskeleton. Curr. Opin. Immunol. 2007, 19(4):402-407.
85. Nathans R., Chu C.Y., Serquina A.K., Lu C.C., Cao H., Rana T.M. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 2009, 34(6):696-709.
86. NCI Frederick. Proteins in HIV Database. URL: 〈〉. http://ncifrederick.cancer.gov/research/avp/protein_db.asp.
87. Nisole S., Krust B., Hovanessian A.G. Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. Exp. Cell Res. 2002, 276(2):155-173.
88. Ohashi S., Koike K., Omori A., Ichinose S., Ohara S., Kobayashi S., Sato T.A., Anzai K. Identification of mRNA/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J. Biol. Chem. 2002, 277(40):37804-37810.
89. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 2002, 1:376-386.
90. Ono A. Relationships between plasma membrane microdomains and HIV-1 assembly. Biol. Cell 2010, 102(6):335-350.
91. Pavon-Eternod M., Wei M., Pan T., Kleiman L. Profiling non-lysyl tRNAs in HIV-1. RNA 2010, 16(2):267-273.
92. Phalora P.K., Sherer N.M., Wolinsky S.M., Swanson C.M., Malim M.H. HIV-1 replication and APOBEC3 antiviral activity are not regulated by P bodies. J. Virol. 2012, 86(21):11712-11724.
93. Pinney J.W., Dickerson J.E., Fu W., Sanders-Beer B.E., Ptak R.G., Robertson D.L. HIV-host interactions. a map of viral perturbation of the host system. AIDS 2009, 23(5):549-554.
94. Poole E., Strappe P., Mok H.P., Hicks R., Lever A.M. HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 2005, 6(9):741-755.
95. Poon D.T., Wu J., Aldovini A. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. J. Virol. 1996, 70:6607-6616.
96. Ptak R.G., Fu W., Sanders-Beer B.E., Dickerson J.E., Pinney J.W., Robertson D.L., Rozanov M.N., Katz K.S., Maglott D.R., Pruitt K.D., Dieffenbach C.W. Cataloguing the HIV type 1 human protein interaction network. AIDS Res. Hum. Retrovir. 2008, 24(12):1497-1502.
97. Reed J.C., Molter B., Geary C.D., McNevin J., McElrath J., Giri S., Klein K.C., Lingappa J.R. HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly. J. Cell Biol. 2012, 198(3):439-456.
98. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Seraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999, 17:1030-1032.
99. Rothbauer U., Zolghadr K., Muyldermans S., Schepers A., Cardoso M.C., Leonhardt H. A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol. Cell Proteomics 2008, 7:282-289.
100. Roy B.B., Hu J., Guo X., Russell R.S., Guo F., Kleiman L., Liang C. Association of RNA helicase a with human immunodeficiency virus type 1 particles. J. Biol. Chem. 2006, 281:12625-12635.
101. Santos S., Obukhov Y., Nekhai S., Bukrinsky M., Iordanskiy S. Virus-producing cells determine the host protein profiles of HIV-1 virion cores. Retrovirology 2012, 9:65.
102. Schäfer A., Bogerd H.P., Cullen B.R. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Virology 2004, 328:163-168.
103. Selig L., Pages J.C., Tanchou V., Preveral S., Berlioz-Torrent C., Liu L.X., Erdtmann L., Darlix J., Benarous R., Benichou S. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J. Virol. 1999, 73(1):592-600.
104. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape. a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13:2498-2504.
105. Shepard P.J., Hertel K.J. The SR protein family. Genome Biol. 2009, 10(10):242.
106. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
107. Stolp B., Fackler O.T. How HIV takes advantage of the cytoskeleton in entry and replication. Viruses 2011, 3(4):293-311.
108. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
109. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(14):5514-5519.
110. Studamire B., Goff S.P. Host proteins interacting with the Moloney murine leukemia virus integrase. multiple transcriptional regulators and chromatin binding factors. Retrovirology 2008, 5:48.
111. Sundquist W.I., Kräusslich H.G. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2012, 2(7):a006924.
112. Swanson C.M., Sherer N.M., Malim M.H. SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J. Virol. 2010, 84:6748-6759.
113. The Common Repository of Adventitious Proteins - cRAP. URL: ftp://ftp.thegpm.org/fasta/cRAP/crap.fasta.
114. Tang Y., Winkler U., Freed E.O., Torrey T.A., Kim W., Li H., Goff S.P., Morse H.C. Cellular motor protein KIF-4 associates with retroviral Gag. J. Virol. 1999, 73:10508-10513.
115. Thali M., Bukovsky A., Kondo E., Rosenwirth B., Walsh C.T., Sodroski J., Gottlinger H.G. Functional association of cyclophilin A with HIV-1 virions. Nature 1994, 372:363-365.
116. Thomas P.D., Campbell M.J., Kejariwal A., Mi H., Karlak B., Daverman R., Diemer K., Muruganujan A., Narechania A. PANTHER. a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13:2129-2141.
117. Triboulet R., Mari B., Lin Y.L., Chable-Bessia C., Bennasser Y., Lebrigand K., Cardinaud B., Maurin T., Barbry P., Baillat V., Reynes J., Corbeau P., Jeang K.T., Benkirane M. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315(5818):1579-1582.
118. Trinkle-Mulcahy L., Boulon S., Lam Y.W., Urcia R., Boisvert F.M., Vandermoere F., Morrice N.A., Swift S., Rothbauer U., Leonhardt H., Lamond A. Identifying specific protein interaction partners using quantitative mass spectrometry and bead proteomes. J. Cell Biol. 2008, 183:223-239.
119. Twyffels L., Gueydan C., Kruys V. Shuttling SR proteins. more than splicing factors. FEBS J. 2011, 278(18):3246-3255.
120. Ueno T., Tokunaga K., Sawa H., Maeda M., Chiba J., Kojima A., Hasegawa H., Shoya Y., Sata T., Kurata T., Takahashi H. Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1). Microbiol. Immunol. 2004, 48(2):111-118.
121. Usami Y., Popov S., Gottlinger H.G. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J. Virol. 2007, 81(12):6614-6622.
122. Vermeulen M., Hubner N.C., Mann M. High confidence determination of specific protein-protein interactions using quantitative mass spectrometry. Curr. Opin. Biotechnol. 2008, 19:331-337.
123. Villace P., Marion R.M., Ortin J. The composition of Staufen-containing RNA granules from human cells indicates their role in the regulated transport and translation of messenger RNAs. Nucleic Acids Res. 2004, 32(8):2411-2420.
124. Wang X., Han Y., Dang Y., Fu W., Zhou T., Ptak R.G., Zheng Y.H. Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J. Biol. Chem. 2010, 285(19):14346-14355.
125. Weidensdorfer D., Stohr N., Baude A., Lederer M., Kohn M., Schierhorn A., Buchmeier S., Wahle E., Huttelmaier S. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA 2009, 15(1):104-115.
126. Wilk T., Gowen B., Fuller S.D. Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J. Virol. 1999, 73:1931-1940.
127. Xing L., Liang C., Kleiman L. Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J. Virol. 2011, 85(4):1847-1860.
128. Yeung M.L., Houzet L., Yedavalli V.S., Jeang K.T. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J. Biol. Chem. 2009, 284(29):19463-19473.
129. Zennou V., Perez-Caballero D., Gottlinger H., Bieniasz P.D. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 2004, 78:12058-12061.
130. Zhong X.Y., Ding J.H., Adams J.A., Ghosh G., Fu X.D. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 2009, 23(4):482-495.
131. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., Espeseth A.S. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495-504.
132. Zhou Y., Rong L., Lu J., Pan Q., Liang C. Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. J. Virol. 2008, 82:5683-5692.
133. Zhu Y., Chen G., Lv F., Wang X., Ji X., Xu Y., Sun J., Wu L., Zheng Y.T., Gao G. Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(38):15834-15839.